Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Yousefi

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Life Sciences|November 7, 2020
Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesisParisa Ghaffari-Makhmalbaf, Maryam Sayyad, Katayoon Pakravan, et al.
Tumori|July 20, 2018
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancerHassan Yousefi, Majid Momeny, Seyed H Ghaffari, et al.
The Journal of Physical Chemistry Letters|November 12, 2025
Green and Selective Oxidation of Benzyl Alcohol to Benzaldehyde over Transition Metal LDH Nanosheets: Combining Experiments and DFT CalculationsSeyedsaeed Mehrabi-Kalajahi, Seyed Amir Hossein Vasigh, Xin-Zhao Wu, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cellsMajid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Scientific Reports|April 7, 2017
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cellsMajid Momeny, Zahra Sabourinejad, Ghazaleh Zarrinrad, et al.
Scientific Reports|March 14, 2017
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cellsMajid Momeny, Farima Moghaddaskho, Narges K Gortany, et al.
Scientific Reports|June 25, 2017
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsMajid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, et al.
The International Journal of Biochemistry & Cell Biology|March 24, 2018
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cellsMajid Momeny, Hassan Yousefi, Haniyeh Eyvani, et al.
Frontiers in Bioscience (Landmark Edition)|June 24, 2022
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival CorrelationsKhoa Nguyen, Hassan Yousefi, Thomas Cheng, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Life Sciences|November 7, 2020
Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesisParisa Ghaffari-Makhmalbaf, Maryam Sayyad, Katayoon Pakravan, et al.
Tumori|July 20, 2018
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancerHassan Yousefi, Majid Momeny, Seyed H Ghaffari, et al.
The Journal of Physical Chemistry Letters|November 12, 2025
Green and Selective Oxidation of Benzyl Alcohol to Benzaldehyde over Transition Metal LDH Nanosheets: Combining Experiments and DFT CalculationsSeyedsaeed Mehrabi-Kalajahi, Seyed Amir Hossein Vasigh, Xin-Zhao Wu, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cellsMajid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Scientific Reports|April 7, 2017
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cellsMajid Momeny, Zahra Sabourinejad, Ghazaleh Zarrinrad, et al.
Scientific Reports|March 14, 2017
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cellsMajid Momeny, Farima Moghaddaskho, Narges K Gortany, et al.
Scientific Reports|June 25, 2017
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cellsMajid Momeny, Ghazaleh Zarrinrad, Farima Moghaddaskho, et al.
The International Journal of Biochemistry & Cell Biology|March 24, 2018
Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cellsMajid Momeny, Hassan Yousefi, Haniyeh Eyvani, et al.
Frontiers in Bioscience (Landmark Edition)|June 24, 2022
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival CorrelationsKhoa Nguyen, Hassan Yousefi, Thomas Cheng, et al.
Pageof 7